REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Takeda Pharma Kft. (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Takeda Pharma Kft. Profile Updated: October 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Nycomed is an international group which is engaged in pharmaceutical manufacturing. The group offers solutions for gatroenterology, respiratory, pain management, osteoporosis, tissue management and further therapies.

Headquarters
Nepfurdo utca 22. 14. em.
Budapest; Budapest; Postal Code: 1138

Contact Details: Purchase the Takeda Pharma Kft. report to view the information.

Website: http://www.nycomed.hu

Basic Information
Total Employees:
Purchase the Takeda Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Takeda Pharma Kft. report to view the information.
Registered Capital:
Purchase the Takeda Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Takeda Pharma Kft. report to view the information.
Incorporation Date:
August 03, 2004
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Takeda Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-3.44%▼
Total operating revenue
-2.08%▼
Operating profit (EBIT)
-45.35%▼
EBITDA
-19.82%▼
Net Profit (Loss) for the Period
-40%▼
Total assets
10.03%▲
Total equity
2.91%▲
Operating Profit Margin (ROS)
-1.93%▼
Net Profit Margin
-1.51%▼
Return on Equity (ROE)
-2.02%▼
Quick Ratio
-0.45%▼
Cash Ratio
-0.14%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo